Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameMEDTRONIC KINETRA MODEL 7428 IMPLANTABLE NEUROSTIMULATION SYSTEM
Classification Namestimulator, electrical, implanted, for parkinsonian tremor
Generic Nameimplantable electrical thalmic stimulation system - deep brain stimulation
ApplicantMEDTRONIC VASCULAR
PMA NumberP960009
Supplement NumberS027
Date Received08/27/2002
Decision Date12/16/2003
Product Code
MHY[ Registered Establishments with MHY ]
Advisory Committee Neurology
Supplement Typenormal 180 day track
Supplement Reason change design/components/specifications - other
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the medtronic kinetra model 7428 implantable neurostimulation system which includes the model 7428 kinetra neurostimulator, model 7436 access therapy controller, model 8840 n'vision programmer, model 8870 software application card, model 7459 memorymod software cartridge, and model 3550-09 accessory kit. These are revisions to the existing medtronic activa parkinson's control therapy also known as the activa system. The medtronic kinetra model 7428 implantable neurostimulation system is only indicated for bilateral stimulation of the internal globus pallidus (gpi) or the subthalamic nucleus (stn) as an adjunctive therapy in reducing some of the symptoms of advanced, levodopa-responsive parkinson's disease that are not adequately controlled with medication. Additionally, this supplement also incorporates the latest magnetic resonance imaging (mri) labeling information with respect to the above systems.
-
-